Spots Global Cancer Trial Database for who grade ii
Every month we try and update this database with for who grade ii cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) | NCT02924038 | Glioma Malignant Gliom... Astrocytoma, Gr... Oligodendroglio... Glioma, Astrocy... Oligoastrocytom... | IMA950 poly-ICLC Varlilumab | 18 Years - | University of California, San Francisco | |
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) | NCT02924038 | Glioma Malignant Gliom... Astrocytoma, Gr... Oligodendroglio... Glioma, Astrocy... Oligoastrocytom... | IMA950 poly-ICLC Varlilumab | 18 Years - | University of California, San Francisco | |
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) | NCT02924038 | Glioma Malignant Gliom... Astrocytoma, Gr... Oligodendroglio... Glioma, Astrocy... Oligoastrocytom... | IMA950 poly-ICLC Varlilumab | 18 Years - | University of California, San Francisco | |
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma | NCT02549833 | Oligodendroglio... Astrocytoma, Gr... Glioma, Astrocy... Glioma Malignant Gliom... Oligoastrocytom... | GBM6-AD and pol... GBM6-AD and pol... | 18 Years - | University of California, San Francisco |